5-Acetyl-2-arylbenzimidazoles as antiviral agents. Part 4

European Journal of Medicinal Chemistry

Volumn 53, Issue , 2012, Pages 83-97

  Vitale, Gabriella ^a   Corona, Paola ^a   Loriga, Mario ^a   Carta, Antonio ^a   Paglietti, Giuseppe ^a   Giliberti, Gabriele ^b   Sanna, Giuseppina ^b   Farci, Pamela ^b   Marongiu, Maria Elena ^b   La Colla, Paolo ^b  

^a UNIVERSITY OF SASSARI   (Italy)

^b Cittadella Universitaria   (Italy)

Author keywords

5 Acetyl 2 arylbenzimidazoles; Antiflaviviridae virus activity; Ketoximes; Semi and thiosemicarbazones

Indexed keywords

1 [2 (2,3,4 TRIMETHOXYPHENYL) 1H BENZIMIDAZOL 5 YL]ETHANOL; 1 [2 (2,3,4 TRIMETHOXYPHENYL) 1H BENZIMIDAZOL 5 YL]ETHANONE OXIME; 1 [2 (2,4 DIMETHOXYPHENYL) 1H BENZIMIDAZOL 5 YL]ETHANOL; 1 [2 (2,4 DIMETHOXYPHENYL) 1H BENZIMIDAZOL 5 YL]ETHANONE OXIME; 1 [2 (4 CHLOROPHENYL) 1H BENZIMIDAZOL 5 YL]ETHANONE OXIME; 1 [2 (4 METHOXYPHENYL) 1H BENZIMIDAZOL 5 YL]ETHANOL; 1 [2 (4 METHOXYPHENYL) 1H BENZIMIDAZOL 5 YL]ETHANONE OXIME; 1 [2 (4 TRIFLUOROMETHYLPHENYL) 1H BENZIMIDAZOL 5 YL]ETHANONE OXIME; 1 CYCLOHEXYL 2 (2,4 DIMETHOXYPHENYL) 5 ACETYL 1H BENZIMIDAZOLE; 1 CYCLOHEXYL 2 (4 CHLOROPHENYL) 5 ACETYL 1H BENZIMIDAZOLE; 1 CYCLOHEXYL 2 (4 METHOXYPHENYL) 5 ACETYL 1H BENZIMIDAZOLE; 1 CYCLOHEXYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 ACETYL 1H BENZIMIDAZOLE; 1 CYCLOHEXYL 2 [FURAN 3 YL] 5 ACETYL 1H BENZIMIDAZOLE; 1 CYCLOHEXYL 2 [PYRIDIN 2 YL] 5 ACETYL 1H BENZIMIDAZOLE; 1 CYCLOHEXYL 2 PHENYL 5 ACETYL 1 H BENZIMIDAZOLE; 1 CYCLOHEXYL 2 PHENYL 5 ACETYL 1H BENZIMIDAZOLE; 2 (3 FURANYL) 5 ACETYL 1H BENZIMIDAZOLE; 2 (4 TRIFLUOROMETHYLPHENYL) 5 ACETYL 1H BENZIMIDAZOLE; 2 (CYCLOHEXYL) 5 ACETYL 1H BENZIMIDAZOLE; 2 [1 (1 CYCLOHEXYL 2 (FURAN 3 YL) 1H BENZIMIDAZOL 5 YL)ETHYLIDENE]HYDRAZINECARBOAMIDE; 2 [1 (1 CYCLOHEXYL 2 PHENYL 1H BENZIMIDAZOL 5 YL)ETHYLIDENE]HYDRAZINECARBOXAMIDE; 2 [1 (2 (2,4 DIMETHOXYPHENYL) 1H BENZIMIDAZOL 5 YL)ETHYLIDENE]HYDRAZINECARBOXAMIDE; 2 [1 (2 (2,4 DIMETHOXYPHENYL) 1H BENZIMIDAZOL 5 YL]ETHYLIDENE)HYDRAZINECARBOTHIOAMIDE; 2 [1 (2 (4 CHLOROPHENYL) 1H BENZIMIDAZOL 5 YL)ETHYLIDENE]HYDRAZINECARBOTHIOAMIDE; 2 [1 (2 PHENYL 1H BENZIMIDAZOL 5 YL)ETHYLIDENE]HYDRAZINECARBOTHIOAMIDE; 2 [1 (2 PHENYL 1H BENZIMIDAZOL 5 YL)ETHYLIDENE]HYDRAZINECARBOXAMIDE; ANTIVIRUS AGENT; DOUBLE STRANDED RNA; SINGLE STRANDED RNA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DNA VIRUS; DRUG DESIGN; DRUG SYNTHESIS; FLAVIVIRUS; HEPATITIS C VIRUS; NONHUMAN; PESTIVIRUS;

ANIMALS; ANTIVIRAL AGENTS; BENZIMIDAZOLES; CATTLE; CELL LINE; CRICETINAE; DRUG DESIGN; VIRUSES;

EID: 84861646687     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.03.038     Document Type: Article

References (36)

1. G. Paglietti, and F. Sparatore Dialchilaminoalchilbenzimidazoli d'interesse farmacologico Nota III. Il Farmaco, Ed.Sci. 27 1972 335 342
2. G. Paglietti, V. Boido, and F. Sparatore Dialchilaminoalchilbenzimidazoli di interesse farmacologico Nota IV. Il Farmaco, Ed.Sci. 30 1974 505 511
3. G. Paglietti, and F. Sparatore Preparazione di acidi β- benzimidazolil- e indazolil-butirrici quali potenziali coleretici Il Farmaco, Ed. Sci. 27 1972 471 479
4. G. Grella, G. Paglietti, F. Sparatore, P. Manca, and M. Satta Sintesi ed attività coleretica di acidi 3-(2-aril-5R-benzimidazol-l-il)butanoici Il Farmaco, Ed. Sci. 42 1987 475 490
5. G. Paglietti, M.A. Pirisi, M. Loriga, G. Grella, F. Sparatore, M. Satta, P. Manca, and A. Peana Preparazione ed attività farmacologica di 2-(4′R′)benzil-5R-benzimidazoli. Attività analgesica e sull'acquisizione di una risposta condizionata di avoidance Il Farmaco, Ed.Sci. 43 1988 203 214
6. G. Paglietti, M.A. Pirisi, M. Loriga, G. Grella, F. Sparatore, M. Satta, and P. Manca Preparazione ed attività farmacologica di 2-(4′R′)fenil-5R-benzimidazoli e 2-(4′piridinil)-5R- benzimidazoli. Attività analgesica e sull'acquisizione di una risposta condizionata di avoidance Il Farmaco, Ed. Sci. 43 1988 215 226
7. G. Vitale, A. Carta, M. Loriga, G. Paglietti, R. Loddo, B. Busonera, D. Collu, and P. La Colla 2-Arylbenzimidazoles as antiviral and antiproliferative agents - part 1 Med. Chem. 4 2008 605 615
8. G. Vitale, P. Corona, M. Loriga, A. Carta, G. Paglietti, P. La Colla, B. Busonera, E. Marongiu, D. Collu, and R. Loddo 2-Arylbenzimidazoles as antiviral and antiproliferative agents - part 2 Med. Chem. 5 2009 507 516
9. G. Vitale, P. Corona, M. Loriga, A. Carta, G. Paglietti, C. Ibba, G. Giliberti, R. Loddo, P. La Colla, and E. Marongiu Styrylbenzimidazoles. Synthesis and biological activity - part 3 Med. Chem. 6 2010 70 78
10. M. Tonelli, G. Paglietti, V. Boido, F. Sparatore, F. Marongiu, E. Marongiu, P. La Colla, and R. Loddo Antiviral activity of benzimidazole derivatives. I. Antiviral activity of 1-substituted-2-[(benzotriazol-1/2-yl) methyl]benzimidazoles Chem. Biodivers. 5 2008 2386 2401
11. P.H. Hayashi, and A.M. Di Bisceglie The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: epidemiology and pathogenesis Med. Clin. North Am. 89 2005 371 389
12. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, Antwerp Belgium. J. Viral Hepat. 6 1999 35 47
13. M.I. Memon, and M.A. Memon Hepatitis C: an epidemiological review J. Viral Hepat. 9 2002 84 100
14. J.M. Echevarria-Mayo Etiology and pathogenesis of viral hepatitis Enferm. Infect. Microbiol. Clin. 24 2006 4 56
15. F.X. Bosch, J. Ribes, R. Cleries, and M. Diaz Epidemiology of hepatocellular carcinoma Clin. Liver Dis. 9 2005 191 211
16. M.W. Fried, M.L. Shiffman, K.R. Reddy, C. Smith, G. Marinos, F.L. Gonçales Jr., D. Häussinger, M. Diago, G. Carosi, D. Dhumeax, A. Craxi, A. Lin, J. Hoffman, and J. Yu Peg-interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N. Engl. J. Med. 347 2002 975 982
17. T.P. Monath Yellow fever as an endemic/epidemic disease and priorities for vaccination Bull. Soc. Pathol. Exot. 99 2006 341 347
18. A.M. O'Connor, S.D. Sorden, and M.D. Apley Association between the existence of calves persistently infected with bovine viral diarrhoea virus and commingling on pen morbidity in feedlot cattle Am. J. Vet. Res. 66 2005 2130 2134
19. C.C. Chase, G. Elmowalid, and A.A. Yousif The immune response to bovine viral diarrhoea virus: a constantly changing picture Vet. Clin. North Am. Food Anim. Pract. 20 2004 95 114
20. B.R. Bacon, S.C. Gordon, E. Lawitz, P. Marcellin, J.M. Vierling, and S. Zeuzem Boceprevir for previously treated chronic HCV genotype 1 infection N. Engl. J. Med. 364 2011 1207 1217
21. I.M. Jacobson, J.G. McHutchison, G. Dusheiko, A.M. Di Bisceglie, K.R. Reddy, and N.H. Bzowej Telaprevir for previously untreated chronic hepatitis C virus infection N. Engl. J. Med. 364 2011 2405 2416
22. F. Poordad, J. McCone, B.R. Bacon, S. Bruno, M.P. Manns, and M.S. Sulkowski Boceprevir for untreated chronic HCV genotype 1 infection N. Engl. J. Med. 364 2011 1195 1206
23. S. Zeuzem, P. Andreone, S. Pol, E. Lawitz, M. Diago, and S. Roberts Telaprevir for retreatment of HCV infection N. Engl. J. Med. 364 2011 2417 2428
24. M. Tonelli, M. Simone, B. Tasso, F. Novelli, V. Boido, F. Sparatore, G. Paglietti, S. Pricl, P. La Colla, G. Giliberti, S. Blois, C. Ibba, G. Sanna, and R. Loddo Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives Bioorg. Med. Chem. 18 2010 2937 2953
25. Hashimoto, H.; Mizutani, K.; Yoshida, A.; Japan Tobacco Inc. Japan, U.S. Patent Appl. Publ. US 2003 50, 320; Chem. Abstr., 2003, 138, 238181c.
26. Priestley, E.S.; Decicco, C.P.; Hudyma, T.W.; Zheng, X. (Bristol- Meyers-Squibb Company, USA) PCT Int. Appl. WO 03 26, 587, 3 Apr 2003, C.A, 2003, 138, 287673y, 896.
27. S. Hirashima, T. Suzuki, T. Ispida, S. Noji, S. Yata, I. Ando, M. Komatsu, S. Ikeda, and H. Hashimoto Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: structure-activity relationship studies and identification of a potent and highly selective inhibitor JTK-109 J. Med. Chem. 49 2006 4721 4736
28. J.H. Wikel, C.J. Paget, D.C. DeLong, J.D. Nelson, C.Y.E. Wu, J.W. Paschal, A. Dinner, R.J. Templeton, and M.O. Chaney Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H- benzimidazol-2-amine. Inhibitors of rhinovirus multiplication J. Med. Chem. 23 1980 368
29. F. Victor, R. Loncharich, J. Tang, and W.A. Spitzer Synthessis and antiviral activity od C2 analogs of enviroxime.an exploration of the role of critical functionality J. Med. Chem. 40 1997 3478
30. C. Shipman Jr., S.H. Smith, J.C. Drach, and D.L. Klayman Antiviral activity of 2-acetylpyridine thiosemicarbazone against herpes simplex virus Antimicrob. Agents Chemother. 19 1981 682
31. D.J. Bauer, and P.W. Sadler The structure-activity relationships of the antiviral chemotherapeutic activity of isatin β-thiosemicarbazone Br. J.Pharmacol. Chemother. 15 1960 101
32. P.L. Beaulieu, M. Bös, Y. Bousquet, G. Fazal, J. Gauthier, J. Gillard, S. Goulet, S. La Plante, M.A. Poupart, S. Lefebvre, G. Mc Kercher, C. Pellerin, V. Austel, and G. Kukolj Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives Bioorg. Med. Chem. Lett. 14 2004 119 124
33. P.L. Beaulieu, M. Bös, Y. Bousquet, P. De Roy, G. Fazal, J. Gauthier, J. Gillard, S. Goulet, G. Mc Kercher, M.A. Poupart, S. Valois, and G. Kukolj Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency Bioorg. Med. Chem. Lett. 14 2004 967 971
34. W. Borsche, and J. Barthenheier Über Kern-acylierung nach Friedel-Crafts. II Liebig's Ann. der Chem. 553 1942 250 259
35. R.L. Shriner, and A. Land The structure of the bisulfite compound of acetaldehyde J. Org. Chem. 6 1941 888
36. R. Pauwels, J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Herdewijn, J. Desmyter, and E. De Clercq A rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compound J. Virol. Methods 20 1988 309 321